EP 3283055 A1 20180221 - NATURAL-SUBSTANCE COMBINATION CONTAINING AT LEAST ONE GLYCYRRHETINIC ACID AND AT LEAST ONE GUGGELSTERONE AND USE THEREOF FOR COSMETIC APPLICATIONS
Title (en)
NATURAL-SUBSTANCE COMBINATION CONTAINING AT LEAST ONE GLYCYRRHETINIC ACID AND AT LEAST ONE GUGGELSTERONE AND USE THEREOF FOR COSMETIC APPLICATIONS
Title (de)
NATURSTOFFKOMBINATION ENTHALTEND MINDESTENS EINE GLYCYRRHETINSÄURE UND MINDESTENS EIN GUGGULSTERON SOWIE VERWENDUNG DERSELBEN FÜR KOSMETISCHE ANWENDUNGEN
Title (fr)
COMBINAISON DE SUBSTANCES NATURELLES CONTENANT AU MOINS UN ACIDE GLYCYRRHÉTINIQUE ET AU MOINS UN GUGGULSTÉRONE, ET UTILISATION DE CETTE DERNIÈRE POUR DES APPLICATIONS COSMÉTIQUES
Publication
Application
Priority
- EP 15001045 A 20150413
- EP 15003170 A 20151105
- EP 2016057995 W 20160412
Abstract (en)
[origin: WO2016166091A1] The invention relates to a natural-substance combination containing at least one glycyrrhetinic acid and at least one guggulsterone, and to the use thereof for cosmetic applications. The invention relates in particular to vesicles (in particular for topical application) that contain at least one glycyrrhetinic acid and at least one guggulsterone. Said vesicles are preferably added to a cream, a lotion, or a gel, wherein the resulting cream, the resulting lotion, or the resulting gel is used for the cosmetic and/or dermatological treatment of the skin and/or for preventing the manifestation of cellulite and/or aged skin and/or for treating changes in the subcutaneous fat tissue or connective tissue, such as lipomas and other unspecific subcutaneous fat deposits, or for resolving or reducing non-pathological fat pads, such as fat pads in the face and neck region, for example lachrymal sacs.
IPC 8 full level
A61K 8/00 (2006.01); A61K 9/06 (2006.01); A61K 9/127 (2006.01); A61K 36/00 (2006.01)
CPC (source: CN EP KR US)
A61K 8/0212 (2013.01 - CN EP KR US); A61K 8/0216 (2013.01 - CN); A61K 8/042 (2013.01 - CN EP US); A61K 8/14 (2013.01 - CN EP KR US); A61K 8/34 (2013.01 - CN US); A61K 8/37 (2013.01 - CN EP US); A61K 8/375 (2013.01 - US); A61K 8/553 (2013.01 - CN EP KR US); A61K 8/602 (2013.01 - EP US); A61K 8/63 (2013.01 - CN EP KR US); A61K 8/922 (2013.01 - CN EP US); A61K 8/9789 (2017.07 - US); A61K 9/06 (2013.01 - CN EP KR US); A61K 9/127 (2013.01 - CN EP KR US); A61K 36/00 (2013.01 - EP US); A61K 36/328 (2013.01 - CN EP KR US); A61K 36/484 (2013.01 - CN EP KR US); A61P 3/00 (2017.12 - EP); A61P 3/06 (2017.12 - EP); A61P 7/10 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/18 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61Q 19/00 (2013.01 - CN EP US); A61Q 19/06 (2013.01 - KR US); A61Q 19/08 (2013.01 - CN KR US); A61K 2300/00 (2013.01 - KR); A61K 2800/5922 (2013.01 - US)
Citation (search report)
See references of WO 2016166091A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2016166091 A1 20161020; AU 2016249759 A1 20171102; BR 112017021950 A2 20180710; CA 2982397 A1 20161020; CN 107438422 A 20171205; EP 3283055 A1 20180221; JP 2018514506 A 20180607; KR 20170134746 A 20171206; MX 2017012815 A 20180502; PH 12017501756 A1 20180402; RU 2017139120 A 20190513; RU 2017139120 A3 20190717; TW 201701861 A 20170116; US 2018207078 A1 20180726; ZA 201706881 B 20190925
DOCDB simple family (application)
EP 2016057995 W 20160412; AU 2016249759 A 20160412; BR 112017021950 A 20160412; CA 2982397 A 20160412; CN 201680021508 A 20160412; EP 16715566 A 20160412; JP 2017539260 A 20160412; KR 20177032677 A 20160412; MX 2017012815 A 20160412; PH 12017501756 A 20170925; RU 2017139120 A 20160412; TW 105111490 A 20160413; US 201615336764 A 20160413; ZA 201706881 A 20171011